| Trial ID: | L1091 |
| Source ID: | NCT02012725
|
| Associated Drug: |
Arm 1 Mri With Gadolinium
|
| Title: |
Molecular MRI of the Fibrotic Heart
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Healthy|Myocardial Fibrosis|Chronic Kidney Disease
|
| Interventions: |
DRUG: Arm 1 MRI with gadolinium
|
| Outcome Measures: |
Primary: Arm 1 - Validation of gadolinium free fibrosis imaging against current standard of care LGE-CMR, Results from this arm will focus on validating cine FI measured from MT-weighted bSSFP cine CMR against LGE-CMR and MOLLI characterization of fibrosis in patients referred to the Gill Heart Institute., 36 months|Arm 2 - Imaging of myocardial fibrosis in CKD patients, Will test the hypothesis that MT-weighted CMR can be applied to identify fibrotic remodeling in the hearts of CKD5 patients, 48 months |
|
| Sponsor/Collaborators: |
Sponsor: Moriel Vandsburger
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
125
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2014-01
|
| Completion Date: |
2017-05-01
|
| Results First Posted: |
|
| Last Update Posted: |
2018-01-23
|
| Locations: |
University of Kentucky Medical Center, Lexington, Kentucky, 40536, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02012725
|
